| Primary |
| Asthma |
45.4% |
| Drug Use For Unknown Indication |
16.7% |
| Chronic Obstructive Pulmonary Disease |
13.8% |
| Product Used For Unknown Indication |
8.1% |
| Pulmonary Fibrosis |
2.3% |
| Hypertension |
2.2% |
| Bronchitis |
2.1% |
| Emphysema |
2.0% |
| Hiv Infection |
1.1% |
| Cough |
0.8% |
| Rhinitis |
0.7% |
| Bronchiectasis |
0.7% |
| Angina Pectoris |
0.6% |
| Upper Respiratory Tract Inflammation |
0.6% |
| Epilepsy |
0.5% |
| Pain |
0.5% |
| Prophylaxis |
0.5% |
| Blood Pressure |
0.5% |
| Asthmatic Crisis |
0.5% |
| Depression |
0.4% |
|
| Death |
29.0% |
| Product Quality Issue |
11.0% |
| Pneumonia |
8.8% |
| Pulmonary Fibrosis |
6.1% |
| Respiratory Failure |
5.6% |
| Asthma |
4.5% |
| Dyspnoea |
4.1% |
| Wheezing |
3.8% |
| Overdose |
2.8% |
| Drug Ineffective |
2.8% |
| Pharmaceutical Product Complaint |
2.7% |
| Respiratory Arrest |
2.4% |
| Lung Neoplasm Malignant |
2.3% |
| Lower Respiratory Tract Infection |
2.2% |
| Tremor |
2.2% |
| Vomiting |
2.2% |
| Cardiac Arrest |
2.0% |
| Tachycardia |
2.0% |
| Pulmonary Embolism |
1.8% |
| Infarction |
1.8% |
|
| Secondary |
| Asthma |
34.1% |
| Product Used For Unknown Indication |
16.0% |
| Drug Use For Unknown Indication |
10.0% |
| Chronic Obstructive Pulmonary Disease |
9.5% |
| Migraine |
6.3% |
| Hypertension |
4.6% |
| Osteoarthritis |
3.5% |
| Bronchopneumopathy |
2.5% |
| Hiv Infection |
1.9% |
| Hypothyroidism |
1.7% |
| Emphysema |
1.5% |
| Deep Vein Thrombosis |
1.3% |
| Bronchopulmonary Aspergillosis |
1.2% |
| Epilepsy |
1.2% |
| Prophylaxis |
1.0% |
| Angina Pectoris |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Ill-defined Disorder |
0.8% |
| Coronary Artery Disease |
0.7% |
| Cough |
0.7% |
|
| Weight Increased |
9.1% |
| Wheezing |
9.1% |
| Dyspnoea |
7.9% |
| Pneumonia |
7.9% |
| Asthma |
6.1% |
| Drug Ineffective |
6.1% |
| Overdose |
5.5% |
| Transient Ischaemic Attack |
5.5% |
| Lower Respiratory Tract Infection |
4.9% |
| Increased Upper Airway Secretion |
4.3% |
| Nasopharyngitis |
4.3% |
| Cerebrovascular Accident |
3.7% |
| Death |
3.7% |
| Tachycardia |
3.7% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Lobar Pneumonia |
3.0% |
| Pyrexia |
3.0% |
| Sensory Loss |
3.0% |
| Tension |
3.0% |
| Thrombocytopenia |
3.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.0% |
| Product Used For Unknown Indication |
22.2% |
| Asthma |
12.1% |
| Chronic Obstructive Pulmonary Disease |
8.8% |
| Hypertension |
4.5% |
| Rheumatoid Arthritis |
3.9% |
| Prophylaxis |
3.1% |
| Pain |
2.9% |
| Depression |
2.3% |
| Non-small Cell Lung Cancer |
2.3% |
| Osteoporosis |
1.8% |
| Atrial Fibrillation |
1.5% |
| Diabetes Mellitus |
1.4% |
| Constipation |
1.1% |
| Smoking Cessation Therapy |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Hiv Infection |
0.9% |
| Crohn's Disease |
0.8% |
| Bronchitis |
0.8% |
| Insomnia |
0.8% |
|
| Vomiting |
11.6% |
| Pneumonia |
9.0% |
| Asthma |
6.3% |
| Weight Decreased |
6.3% |
| Renal Failure Acute |
5.4% |
| Weight Increased |
5.1% |
| Dyspnoea |
4.8% |
| Respiratory Failure |
4.7% |
| Renal Failure |
4.6% |
| Syncope |
4.3% |
| Urticaria |
4.3% |
| Thrombocytopenia |
4.2% |
| Wheezing |
4.1% |
| Tremor |
3.9% |
| Pulmonary Embolism |
3.8% |
| Tachycardia |
3.8% |
| Pyrexia |
3.6% |
| Somnolence |
3.5% |
| Lower Respiratory Tract Infection |
3.4% |
| White Blood Cell Count Increased |
3.4% |
|
| Interacting |
| Product Used For Unknown Indication |
49.2% |
| Hiv Infection |
14.6% |
| Drug Use For Unknown Indication |
12.4% |
| Asthma |
7.6% |
| Cystic Fibrosis |
4.3% |
| Epicondylitis |
3.2% |
| Erythema |
3.2% |
| Bronchopulmonary Aspergillosis Allergic |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Asthmatic Crisis |
1.1% |
| Diabetes Mellitus |
0.5% |
| Rhinitis Allergic |
0.5% |
|
| Drug Interaction |
12.5% |
| Dyspnoea |
8.3% |
| Hypogammaglobulinaemia |
8.3% |
| Pulmonary Embolism |
8.3% |
| Tachycardia |
8.3% |
| Weight Increased |
8.3% |
| Hepatic Enzyme Increased |
4.2% |
| Hypertension |
4.2% |
| Labelled Drug-drug Interaction Medication Error |
4.2% |
| Lung Disorder |
4.2% |
| Muscle Atrophy |
4.2% |
| Off Label Use |
4.2% |
| Pituitary-dependent Cushing's Syndrome |
4.2% |
| Pneumonia |
4.2% |
| Proteinuria |
4.2% |
| Renal Failure |
4.2% |
| Swelling Face |
4.2% |
|
